Banned Peptides: The WADA Prohibited List, Explained

If you compete in any sport governed by anti-doping rules, “is this peptide banned?” almost always has the same answer: yes. The World Anti-Doping Agency (WADA) publishes a single Prohibited List each year that defines what athletes may not use, and the way that list is built means peptides get caught twice over — once as a class of substances with no regulatory approval, and again under a category written specifically for peptide hormones and growth factors.^[1] This page explains how the list is structured, which peptide categories fall inside it, and how the lines between “banned in sport,” “legal to possess,” and “detectable” actually run. It is a reference, not a workaround: there is no evasion advice here.

How the WADA Prohibited List is organized

The Prohibited List is updated annually and groups banned substances and methods into lettered classes. Some apply at all times (in- and out-of-competition), others only in-competition, and a few are sport-specific. For peptides, two classes do almost all the work: S0, non-approved substances, and S2, peptide hormones, growth factors, related substances and mimetics. Both are prohibited at all times, meaning a positive finding out of competition counts just as much as one on game day.^[1] Understanding these two categories is enough to place nearly every peptide people ask about.

S0: the catch-all for “research” peptides

S0 is the broadest and most under-appreciated category. It prohibits any pharmacological substance that is not addressed by any other section of the list and has no current approval by any governmental regulatory health authority for human therapeutic use — for example, drugs still in pre-clinical or clinical development, discontinued drugs, designer drugs, and substances approved only for veterinary use.^[1] That definition is precisely the legal status of most peptides sold online with a “research use only” label. Because they have never cleared a regulatory approval anywhere, they are non-approved substances by definition, and S0 captures them even when they are not named individually on the list. In practice, the “not for human consumption” framing that lets a vendor sell a peptide is the very thing that puts it under S0 for an athlete. (For what that label means off the field, see our explainer on whether peptides are legal.)

S2: peptide hormones, growth factors and mimetics

The S2 class is written for exactly the molecules the peptide world is built around. It prohibits several families that show up constantly in peptide marketing:^[1]

• Growth-hormone secretagogues and releasing peptides (GHRPs/GHSs). This sweeps in the ghrelin-mimetic GHRPs and oral secretagogues, alongside growth-hormone-releasing hormone (GHRH) analogs such as sermorelin, CJC-1295 and ipamorelin, and hexarelin. WADA lists these by name and class as substances that act on the growth-hormone axis.
• Growth hormone, its fragments, and releasing factors. Human growth hormone itself, plus GH fragments and the factors that release it, all sit in S2.
• Insulin-like growth factor-1 (IGF-1) and its analogs. IGF-1, mechano growth factor, and related growth factors are explicitly prohibited.
• Growth factors that affect muscle, tendon or ligament. This is the wording that captures TB-500 / thymosin-β4, marketed for “recovery,” as a prohibited growth factor affecting connective-tissue and muscle regeneration.

S2 also closes the obvious loophole with the phrase and other substances with similar chemical structure or similar biological effect(s). That “mimetics” language means a novel peptide does not have to be named to be banned — if it mimics a prohibited hormone or growth factor, it is covered.^[1] Between S0 and S2, the practical reality is that almost any injectable peptide an athlete might consider is prohibited in sport.

What about BPC-157?

BPC-157 is the case people ask about most, because for years it was not named on the list. That changed when WADA placed BPC-157 on its Monitoring Program — a separate list of substances WADA watches to detect patterns of misuse in sport, without (yet) prohibiting them outright.^[1] A spot on the Monitoring Program is not the same as a ban, but it is a clear signal of scrutiny and a common precursor to fuller restriction. It would also be a mistake to read “monitored, not prohibited” as a green light: BPC-157 has no regulatory approval anywhere, which means the S0 catch-all logic still looms, and separately the U.S. FDA has flagged it as a significant-risk compounding substance — points we cover in are peptides legal. Always check the current year’s list and Monitoring Program directly, because status can change annually.

Banned in sport is not the same as illegal to own

A crucial distinction gets lost constantly: the WADA Prohibited List governs eligibility to compete, not criminal law. WADA can sanction an athlete — suspensions, stripped results — but it does not make a substance a controlled drug. Most peptides are not scheduled controlled substances in countries like the United States, so possessing them is generally not a criminal offense in the way that possessing a scheduled anabolic steroid can be. The categories answer different questions: WADA asks “may an athlete use this and stay eligible?” while criminal law asks “is mere possession an offense?” A peptide can be firmly banned in sport and simultaneously not a controlled substance to own. For the possession-and-import side of that line — which is its own tangle of FDA, “research use only” framing, and customs — see are peptides legal.

How anti-doping testing detects these

Anti-doping laboratories have invested heavily in catching exactly these molecules. Peptide hormones and growth factors are analyzed by high-resolution mass spectrometry and immunoassay methods, and the annual banned-substance reviews from WADA-accredited laboratories describe a steadily expanding toolkit for small peptides, GHRPs, and growth-hormone-axis compounds.^[2] Growth hormone use in particular is pursued through two complementary strategies: direct detection of the hormone and an indirect biomarker approach that watches downstream markers such as IGF-1 and procollagen type III amino-terminal propeptide (P-III-NP), which rise with GH administration and can flag misuse even when the substance itself has cleared the system.^[3] The detection window varies enormously by compound, dose, and method, which is one reason this page does not attempt to quantify it — doing so would be both unreliable and beside the point. If you want the broader question of whether peptides surface on ordinary medical or employment screens (a very different thing from a WADA-accredited test), see do peptides show up on a drug test.

The honest bottom line

For anyone bound by anti-doping rules, the safe default is to treat peptides as prohibited. S0 captures the non-approved “research” peptides by virtue of their lack of regulatory approval, S2 names the growth-hormone secretagogues, GHRH analogs, GH fragments, IGF-1, and the growth factors like TB-500, and the mimetics clause catches the rest; BPC-157 sits under active monitoring.^[1] Being banned in sport is a separate question from being legal to possess, and both are separate again from being detectable. The only reliable move is to consult the current year’s Prohibited List and Monitoring Program at the source before assuming anything — and, if you compete, to ask your sport’s anti-doping authority rather than a vendor. This is regulatory reference information, not medical or legal advice.